ALDH1A3在肺动脉高压中协调代谢与基因调控
该研究通过RNA测序比较伴或不伴BMPR2突变的肺动脉高压(PAH)患者肺动脉平滑肌细胞(PASMC)与对照PASMC,发现ALDH1A3是上调最显著的代谢基因,且为PAH PASMC高增殖和糖酵解所必需。平滑肌细胞特异性敲除Aldh1a3的小鼠不发生缺氧诱导的肺血管肌化或肺动脉高压,机制涉及核内ALDH1A3将乙醛转化为乙酸生成乙酰辅酶A,乙酰化H3K27并促进NFYA介导的细胞周期和代谢基因转录。
要点
- ALDH1A3在PAH PASMC中表达升高,是其高增殖和糖酵解表型所必需。
- 平滑肌细胞敲除Aldh1a3可阻止小鼠缺氧诱导的肺血管肌化和肺动脉高压。
- ALDH1A3通过核内代谢-表观遗传轴协调组蛋白乙酰化和NFYA转录。
核心结论
- 研究揭示ALDH1A3介导的代谢-转录轴协调细胞能量需求与表观遗传及转录调控,驱动PAH平滑肌细胞增殖。
- 选择性靶向PAH平滑肌细胞而非内皮细胞中的ALDH1A3是具有重要治疗意义的考虑。
研究设计与样本
- 对伴或不伴BMPR2突变的PAH患者肺动脉平滑肌细胞(PASMC)与对照PASMC进行RNA测序。
- 在PAH PASMC中验证ALDH1A3依赖性,并使用平滑肌细胞特异性Aldh1a3敲除的转基因小鼠评估缺氧诱导的肺动脉高压。
主要发现
- PAH PASMC中ALDH1A3 mRNA和蛋白较对照增加,且ALDH1A3为其高增殖和糖酵解特性所必需。
- 平滑肌细胞Aldh1a3敲除小鼠不发生缺氧诱导的肺动脉肌化或肺动脉高压。
- 核ALDH1A3将乙醛转化为乙酸以生成乙酰辅酶A,乙酰化H3K27标记活跃增强子。
- 通过乙酰转移酶KAT2B在NFYA结合位点进行染色质修饰,允许NFY介导的细胞周期和代谢基因转录。
- 伴或不伴BMPR2突变的PAH平滑肌细胞中BMPR2缺失上调ALDH1A3,且PAH PASMC中NFYA和ALDH1A3转录依赖于β-catenin。
临床怎么用
- ALDH1A3可作为PAH平滑肌细胞增殖和糖酵解表型的潜在治疗靶点。
- 靶向ALDH1A3时需考虑选择性作用于平滑肌细胞而非内皮细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic alterations provide substrates that influence chromatin structure to regulate gene expression that determines cell function in health and disease. Heightened proliferation of smooth muscle cells (SMC) leading to the formation of a neointima is a feature of pulmonary arterial hypertension (PAH) and systemic vascular disease. Increased glycolysis is linked to the proliferative phenotype of these SMC. METHODS: RNA sequencing was applied to pulmonary arterial SMC (PASMC) from PAH patients with and without a BMPR2 (bone morphogenetic receptor 2) mutation versus control PASMC to uncover genes required for their heightened proliferation and glycolytic metabolism. Assessment of differentially expressed genes established metabolism as a major pathway, and the most highly upregulated metabolic gene in PAH PASMC was aldehyde dehydrogenase family 1 member 3 (ALDH1A3), an enzyme previously linked to glycolysis and proliferation in cancer cells and systemic vascular SMC. We determined if these functions are ALDH1A3-dependent in PAH PASMC, and if ALDH1A3 is required for the development of pulmonary hypertension in a transgenic mouse. Nuclear localization of ALDH1A3 in PAH PASMC led us to determine whether and how this enzyme coordinately regulates gene expression and metabolism in PAH PASMC. RESULTS: ALDH1A3 mRNA and protein were increased in PAH versus control PASMC, and ALDH1A3 was required for their highly proliferative and glycolytic properties. Mice with Aldh1a3 deleted in SMC did not develop hypoxia-induced pulmonary arterial muscularization or pulmonary hypertension. Nuclear ALDH1A3 converted acetaldehyde to acetate to produce acetyl coenzyme A to acetylate H3K27, marking active enhancers. This allowed for chromatin modification at NFYA (nuclear transcription factor Y subunit α) binding sites via the acetyltransferase KAT2B (lysine acetyltransferase 2B) and permitted NFY-mediated transcription of cell cycle and metabolic genes that is required for ALDH1A3-dependent proliferation and glycolysis. Loss of BMPR2 in PAH SMC with or without a mutation upregulated ALDH1A3, and transcription of NFYA and ALDH1A3 in PAH PASMC was β-catenin dependent. CONCLUSIONS: Our studies have uncovered a metabolic-transcriptional axis explaining how dividing cells use ALDH1A3 to coordinate their energy needs with the epigenetic and transcriptional regulation of genes required for SMC proliferation. They suggest that selectively disrupting the pivotal role of ALDH1A3 in PAH SMC, but not endothelial cells, is an important therapeutic consideration.
引用
- Li D, Shao NY, Moonen JR, et al. ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension. Circulation. 2021. PMID: 33764154. doi:10.1161/CIRCULATIONAHA.120.048845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。